CIPO Patents = 1

EPO Patents = 2

Forward Citations = 17

Loading Chart...

5 inventors (with patents filed for the assignee):

Marc S Penn (5 out of 24 patents)

Rahul Aras (5 out of 5 patents)

Joseph M Pastore (5 out of 94 patents)

4. Timothy J Miller (4 out of 35 patents)

5. Matthew Kiedrowski (1 out of 4 patents)

5 patents: Sort by Forward Citations

1. 9844581 - SDF-1 delivery for treating ischemic tissue (2017-12-19),

2. 8883756 - SDF-1 delivery for treating ischemic tissue (2014-11-11),

3. 8679477 - Use of SDF-1 to mitigate scar formation (2014-03-25),

4. 8513213 - SDF-1 delivery for treating ischemic tissue (2013-08-20),

5. 8513007 - SDF-1 delivery for treating ischemic tissue (2013-08-20),

Juventas Therapeutics, Inc. is a biotechnology company focused on developing regenerative therapies for cardiovascular diseases. Their groundbreaking research aims to harness the body's own healing mechanisms to treat conditions such as heart failure and peripheral artery disease. With a strong emphasis on innovation and patient care, Juventas Therapeutics is dedicated to improving the lives of those affected by cardiovascular disorders.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

5 Patents

#251 in Cleveland, OH

#2,003 in Ohio

#51,545 in US

Cleveland, OH, United States of America

Juventas Therapeutics, Inc.

Forward Citations = 17

5 inventors:

Marc S Penn (5 out of 24 patents)

Rahul Aras (5 out of 5 patents)

Joseph M Pastore (5 out of 94 patents)

4. Timothy J Miller (4 out of 35 patents)

5. Matthew Kiedrowski (1 out of 4 patents)

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]

2 patents (EPO):

Please report any incorrect information to [email protected]